Oscar Health, Inc. (NYSE:OSCR) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have received a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $22.93.

Several equities analysts have weighed in on OSCR shares. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and cut their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock.

Insider Activity at Oscar Health

In related news, EVP Ranmali Bopitiya sold 36,175 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $650,788.25. Following the transaction, the executive vice president now directly owns 251,885 shares in the company, valued at $4,531,411.15. The trade was a 12.56 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This represents a 3.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have bought 1,055,478 shares of company stock worth $14,432,852 and have sold 194,569 shares worth $3,433,319. Corporate insiders own 25.11% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Several large investors have recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC grew its stake in shares of Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock valued at $255,000 after purchasing an additional 844 shares during the period. American International Group Inc. grew its stake in shares of Oscar Health by 1.3% in the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after purchasing an additional 1,009 shares during the period. Summit Trail Advisors LLC grew its stake in shares of Oscar Health by 5.4% in the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock valued at $329,000 after purchasing an additional 1,065 shares during the period. KBC Group NV grew its stake in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares during the period. Finally, Arizona State Retirement System grew its stake in shares of Oscar Health by 3.7% in the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after purchasing an additional 1,351 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Price Performance

NYSE OSCR opened at $17.35 on Friday. Oscar Health has a fifty-two week low of $7.29 and a fifty-two week high of $23.79. The stock’s 50-day moving average is $17.33 and its two-hundred day moving average is $18.06. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market cap of $4.29 billion, a P/E ratio of -289.04 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the business earned ($0.29) earnings per share. Oscar Health’s quarterly revenue was up 68.3% on a year-over-year basis. On average, analysts anticipate that Oscar Health will post -0.01 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.